Pharmacotherapy of alcohol and drug problems

References

• Sellers EM, Kalant H. Alcohol intoxication and withdrawal. N Engl J Med 1976; 294: 757–762
   PubMed Web of Science ®Google Scholar
• Victor M, Brausch C. The role of abstinence in the genesis of alcoholic epilepsy. Epilepsia 1967; 8: 1–20
   PubMedGoogle Scholar
• Gross M, Lewis E, Nagarajan M. An improved quantitative system for assessing the acute alcohol psychoses and related states (TSA and SSA). Advances in experimental medicine and biology. Volume 35: Alcohol intoxication and withdrawal experimental studies, MM Gross. Plenum Press, New York 1973; 365–376
   Google Scholar
• Knott DH, Lerner WD, Davis-Knott T, Fink RD. Decision for alcohol detoxification. A method to standardize patient evaluation. Postgrad Med 1981; 69(5)65–78
   Web of Science ®Google Scholar
• Shaw JM, Kolesar GS, Sellers EM, Kaplan HL, Sandor P. Development of optimal treatment tactics for alcohol withdrawal: I. Assessment and effectiveness of supportive care. J Clin Psychopharmacol 1981; 1: 382–389
   PubMed Web of Science ®Google Scholar
• Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). Br J Addict 1989; 84: 1353–1357
   PubMedGoogle Scholar
• Naranjo CA, Sellers EM, Chater K, Iversen P, Roach C, Sykora K. Nonpharmacologic intervention in acute alcohol withdrawal. Clin Pharmacol Ther 1983; 34: 214–219
   PubMed Web of Science ®Google Scholar
• Sellers EM, Naranjo CA, Harrison M, Devenyi P, Roach C, Sykora K. Diazepam loading: Simplified treatment of alcohol withdrawal. Clin Pharmacol Ther 1983; 34: 822–826
   PubMed Web of Science ®Google Scholar
• Adinoff B, Bone GHA, Linnoila M. Acute ethanol poisoning and the ethanol withdrawal syndrome. Med Toxicol 1988; 3: 172–196
   Google Scholar
• Sellers EM. Alcohol, barbiturate and benzodiazepine withdrawal syndromes: clinical management. Can Med Ass J 1988; 139: 113–118
   PubMed Web of Science ®Google Scholar
• Romach MK, Sellers EM. Management of the alcohol withdrawal syndrome. Annual review of medicine, WP Creger, CH Coggins, EW Hancock. Annual Review Inc., Palo Alto 1991; 42: 322–340, In
   Google Scholar
• Heinala P, Piepponen T, Heikkinen H. Diazepam loading in alcohol withdrawal. Clinical pharmacokinetics. Int. J Clin Pharmacol Ther Toxicol 1990; 28(5)212–217
   Google Scholar
• Bjorkqvist SE, Isohanni M, Makela R, Malinen L. Ambulant treatment of alcohol withdrawal symptoms with carbazepine: A formal multi-centre double-blind comparison with placebo. Acta Psychiatria Scand 1976; 53: 333–342
   PubMed Web of Science ®Google Scholar
• Ritola E, Malinen L. A double-blind comparison of carbamazepine and clomethiazole in the treatment of alcohol withdrawal syndrome. Acta Psychiat Scand 1981; 64: 254–259
   PubMed Web of Science ®Google Scholar
• Butler D, Messiha FS. Alcohol withdrawal and carbamazepine. Alcohol 1986; 3: 113–129
   PubMed Web of Science ®Google Scholar
• Malcolm R, Ballenger JC, Sturgis ET, Anton R. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiat 1989; 146: 617–621
   PubMed Web of Science ®Google Scholar
• Lambie DG, Johnson RH, Vijayasenan ME, Whiteside EA. Sodium valproate in the treatment of the alcohol withdrawal syndrome. Aust NZ J Psychiat 1980; 14: 213–215
   PubMed Web of Science ®Google Scholar
• Wilbur R, Kulik FA. Anticonvulsant drugs in alcohol withdrawal: use of phenytoin, primidone, carbamazepine, valproic acid, and the sedative anti-convulsants. Am J Hosp Pharm 1981; 38: 1138–1143
   Google Scholar
• Gold MS, Redmond DE, Kleber HD. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. Am J Psychiat 1979; 136: 100–102
   PubMed Web of Science ®Google Scholar
• Glassman AH, Jackson WK, Walsh BT, Roose SP. Cigarette craving, smoking, withdrawal and clonidine. Science 1984; 226: 864–866
   PubMed Web of Science ®Google Scholar
• Bjorkqvist SE. Clonidine in alcohol withdrawal. Acta Psychiat Scand 1975; 52: 256–263
   PubMed Web of Science ®Google Scholar
• Manhem P, Nilsson LH, MOberg A-L, Wadstein J, Hokfelt B. Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms. Alcoholism: Clin Exp Res 1985; 9(3)238–243
   Google Scholar
• Baumgartner GR, Rowen RC. Clonidine vs. chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med 1987; 147: 1223–1226
   PubMed Web of Science ®Google Scholar
• Cushman P, Jr., Sowers JR. Alcohol withdrawal syndrome: clinical and hormonal responses to alpha2-adrenergic agonist treatment. Alcoholism: Clin Exp Res 1989; 13: 361–364
   Google Scholar
• Liskow BL, Goodwin DW. Pharmacological treatment of alcohol intoxication, withdrawal and dependence: A critical review. J Stud Alcohol 1987; 48: 356–370
   PubMed Web of Science ®Google Scholar
• Robinson BJ, Robinson GM, Maling TJB, Johnson RH. Is clonidine useful in the treatment of alcohol withdrawal?. Alcoholism: Clin Exp Res 1989; 13: 95–98
   PubMed Web of Science ®Google Scholar
• wilson A, Vulcano B. A double-blind, placebo-controlled trial of magnesium sulfate in the ethanol withdrawal syndrome. Alcoholism: Clin Exp Res 1984; 8: 542–545
   Google Scholar
• Naranjo CA, Sellers EM. Clinical assessment and pharmacotherapy of the alcohol withdrawal syndrome. Recent Development in Alcoholism, M Galanter. Plenum Publishing Corporation, New York 1986; 4: 264–281, In
   Google Scholar
• Young GP, Rores C, Murphy C, Dailey RH. Intravenous phenobarbital for alcohol withdrawal and convulsions. Ann Emerg Med 1987; 16: 847–850
   PubMedGoogle Scholar
• Borg V, Weinholdt T. Bromocriptine in the treatment of the alcohol withdrawal syndrome. Acta Psychiatria Scand 1982; 65: 101–111
   PubMed Web of Science ®Google Scholar
• Burroughs AK, Morgan MY, Sherlock S. Double-blind controlled trial of bromocriptine, chlordiazepoxide, and chlormethiazole for alcohol withdrawal symptoms. Alcohol Alcoholism 1985; 20: 263–271
   PubMed Web of Science ®Google Scholar
• Kaim SC, Klett CJ, Rothfield B. Treatment of the acute alcohol withdrawal state: a comparison of four drugs. Am J Psychiat 1969; 125: 1640–1646
   PubMed Web of Science ®Google Scholar
• Koppi S, Eberhardt G, Haller R, Konig P. Calcium channel blocking agent in the treatment of acute alcohol withdrawal—caroverine versus meprobamate in a randomized double-blind study. Neuropsychobiology 1987; 17: 49–52
   PubMed Web of Science ®Google Scholar
• Gross MM, Lewis E, Hastey J. Acute alcohol withdrawal syndrome. The Biology of Alcoholism, B Kissin, H Begleiter. Plenum Publishing, New York 1974; 3: 191–263, In
   Google Scholar
• Devenyi P, Harrison ML. Prevention of alcohol withdrawal seizures with oral diazepam loading. Can Med Ass J 1985; 132: 798–800
   PubMed Web of Science ®Google Scholar
• Alldredge BK, Lowenstein DH, Simon RP. Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures. Am J Med 1989; 87: 645–648
   PubMed Web of Science ®Google Scholar
• Sellers EM, Kalant H. Alcohol withdrawal and delirium tremens. Encyclopedic handbook of alcoholism, EM Pattison, E Kaufman. Gardner Press, New York 1982; 147–166, In
   Google Scholar
• Zilm DH, Jacob MS, MacLeod SM, Sellers EM, Ti TY. Propranolol and chloradiazepoxide effects on cardiac arrhythmias during alcohol withdrawal. Alcoholism: Clin Exp Res 1980; 4: 400–405
   Google Scholar
• Hesselbrock MN, Meyer RE, Keener JJ. Psychopathology in hospitalized alcoholics. Arch Gen Psychiatry 1985; 42: 1050–1055
   PubMed Web of Science ®Google Scholar
• Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry 1988; 45: 1023–1031
   PubMed Web of Science ®Google Scholar
• Alling, C, Balldin, J, Bokstrom, K, Gottfries, CG, Karlsson, I, et al. Studies on duration of a late recovery period after chronic abuse of ethanol. A cross-sectional study of biochemical and psychiatric indicators. Acta Psychiatria Scand 1982; 66: 384–397
   PubMed Web of Science ®Google Scholar
• De Soto CB, O'Donnell WE, Allred LJ, Lopes CE. Symptomatology in alcoholics at various stages of abstinence. Alcoholism: Clin Exp Res 1985; 9: 505–512
   PubMed Web of Science ®Google Scholar
• Roelofs SM, Dikkenberg GM. Hyperventilation and anxiety: alcohol withdrawal symptoms decreasing with prolonged abstinence. Alcohol 1987; 4: 215–220
   Google Scholar
• Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiat 1987; 44: 505–513
   PubMed Web of Science ®Google Scholar
• Ciraulo DA, Jaffe JH. Tricyclic antidepressants in the treatment of depression associated with alcoholism. J Clin Psychopharmacol 1981; 1: 146–150
   PubMed Web of Science ®Google Scholar
• Ciraulo DA, Sands BF, Shader RI. Critical review of liability for benzodiazeprine abuse among alcoholics. Am J Psychiat 1988; 145: 1501–1506
   PubMed Web of Science ®Google Scholar
• Kahn RS, van Praag HM, Wetzler S, Asnis GM, Barr G. Serotonin and anxiety revisited. Biol Psychiat 1988; 23: 189–208
   PubMed Web of Science ®Google Scholar
• Meyer RE. Anxiolytics and the alcoholic patient. J Stud Alcohol 1986; 47(4)269–273
   Google Scholar
• Kranzler HR. Preliminary studies on the effects of bupsirone on craving in alcoholics. Presented at the Annual Meeting of the American College of Neuropsychopharmacology. 1987
   Google Scholar
• The barbiturate withdrawal syndrome, MH Wolff. Munksgaard, Copenhagen 1959
   Google Scholar
• Ewing JA, Bakewell WE. Diagnosis and management of depressant drug dependence. Am J Psychiat 1967; 123: 909–917
   PubMed Web of Science ®Google Scholar
• Smith DE, Wesson DR. Phenobarbital technique for treatment of barbituate dependence. Arch Gen Psychiat 1971; 24: 56–60
   PubMed Web of Science ®Google Scholar
• Martin PR, Kapur BM, Whiteside EA, Sellers EM. Intravenous phenobarbital therapy in barbiturate and other hypnosedative withdrawal reactions: A kinetic approach. Clin Pharmacol Ther 1979; 26: 356–364
   Google Scholar
• Robinson GM, Sellers EM, Janecek E. Barbiturate and hypnosedative withdrawal by a multiple oral phenobarbital loading dose technique. Clin Pharmacol Ther 1981; 30: 71–76
   PubMed Web of Science ®Google Scholar
• Busto U, Sellers EM, Naranjo C, Cappell H, Sanchez-Craig M, Sykora K. Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 1986; 315: 854–859
   PubMed Web of Science ®Google Scholar
• Griffiths RR, Sannerud CA. Abuse of and dependence on benzodiazepines and other anxiolytic/sedative drugs. Psychopharmacology: the third generation of progress, HY Meltzer. Raven Press, New York 1987; 1535–1542, In
   Google Scholar
• Petursson H, Lader MH. Withdrawal from long-term benzodiazepine treatment. Br Med J 1981; 283: 643–645
   PubMed Web of Science ®Google Scholar
• Owen RT, Tyrer P. Benzodiazepine dependence: a review of the evidence. Drugs 1983; 25: 385–398
   PubMed Web of Science ®Google Scholar
• Tyrer P, Owen R, Dawling S. Gradual withdrawal of diazepam after long-term therapy. Lancet 1983; i: 1402–1406
   Google Scholar
• Romach MK, Busto U, Sobell L, Sobell M, Sellers EM. Long-term alprazolam use: abuse, dependence or treatment?. 29th Annual Meeting of the American College of Neuropsychopharmacology, San JuanPuerto Rico, 1990, (accepted)
   Google Scholar
• Harrison M, Busto U, Naranjo CA, Kaplan H, Sellers EM. Diazepam tapering and detoxification of high-dose benzodiazepine abusers. Clin Pharmacol Ther 1984; 36: 527–535
   PubMedGoogle Scholar
• Sellers EM, Naranjo CA, Peachey JE. Drugs to decrease alcohol consumption. N Engl J Med 1981; 305: 1255–1262
   PubMed Web of Science ®Google Scholar
• Fuller RK, Branchey L, Brightwell DR, Derman RM, Emerick CV, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam R, Maany I, Neiderhiser D, Knocks JJ, Shaw S. Disulfiram treatment of alcoholism: A Veterans Administration cooperative study. J Am Med Ass 1986; 256: 1449–1455
   PubMed Web of Science ®Google Scholar
• Naranjo CA, Sellers EM, Roach CA, Woodley DV, Sanchez-Craig M, Sykora K. Zimelidine-induced variations in alcohol intake in nondepressed heavy drinkers. Clin Pharmacol Ther 1984; 35: 374–381
   PubMed Web of Science ®Google Scholar
• Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K. The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 1987; 41(3)266–274
   Google Scholar
• Naranjo CA, Sullivan JT, Kadlec KE, Woodley-Remus DV, Kennedy G, Sellers EM. Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther 1989; 46(3)301–309
   PubMed Web of Science ®Google Scholar
• Naranjo CA, Kadlec KE, Sanhueza P, Woodley-Remus D, Sellers EM. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 1990; 47(4)490–498
   PubMedGoogle Scholar
• Naranjo CA, Sellers EM, Kadlec KE, Poulos CX. Citalopram decreases the desire for alcohol. Abstracts of Satellite Symposium ‘Novel Pharmacological Interventions for Alcoholism’, 5th ISBRA Conference, Toronto, Ontario, 1990
   Google Scholar
• Naranjo CA, Sellers EM, Kadlec K, Sanhueza P, Grupp L. Enalapril does not decrease alcohol intake in normotensive alcoholics. Abstracts of Satellite Symposium ‘Novel Pharmacological Interventions for Alcoholism’, 5th ISBRA Conference, Toronto, Ontario, 1990
   Google Scholar
• Reynolds TB, Benhamou J-P, Blakd J, Naccarato R, Orrego H. Treatment of acute alcoholic hepatitis. Gastroenterol Int 1989; 2: 208–216
   Google Scholar